Atlas Trials

Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness

Clinical trial NCT03566069 · UNKNOWN

Trial details

NCT number
NCT03566069
Sponsor
Shalvata Mental Health Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Mental Illness
Start date
2018-06-01
Primary completion
2025-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.